EMBCEmbecta Corp.
Surgical & Medical Instruments & Apparatus
- Revenue
- $1.1B
- 3.8% YoY
- Operating margin
- 22.4%
- 51% YoY
- EBITDA
- $283M
- 39% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- -0.8×
- −$215M net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear201% of net incomeCash flow under 80% of net income
- Dilutive SBCClear3% of revenueOver 10% of revenue
- Payouts exceed cash flowClear18% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear3% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.1B | $1.1B | $1.1B | $1.1B | 3.8% |
| Operating income | $492M | $310M | $222M | $167M | $242M | 45% |
| Net income | $415M | $224M | $70M | $78M | $95M | 22% |
| Operating cash flow | $456M | $412M | $68M | $36M | $192M | 437% |
| Capex | $37M | $24M | $27M | $16M | $9M | 41% |
| Stock-based comp | $13M | $19M | $22M | $26M | $32M | 20% |
| Dividends | $0 | $9M | $34M | $35M | $35M | 1.4% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $37K · 1
- Net
- −$37K
Pay vs performance
No pay-versus-performance disclosure yet.